Zenith Drugs Limited (NSE:ZENITHDRUG)
India · Delayed Price · Currency is INR 41.65
+0.55 (1.34%)
Jun 17, 2026, 3:27 PM IST
Zenith Drugs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 39.43 | 71.61 | 95.37 | 48.81 | 31.38 |
Depreciation & Amortization | 60.48 | 29.66 | 13.02 | 13.05 | 13.26 |
Loss (Gain) From Sale of Assets | -0.33 | -2.46 | - | - | - |
Loss (Gain) From Sale of Investments | - | -0.46 | - | - | - |
Other Operating Activities | -1.64 | 3 | -2.38 | 22.57 | 20.87 |
Change in Accounts Receivable | -127.78 | 68.17 | -180.83 | -172.43 | -86.86 |
Change in Inventory | -28.1 | -138.54 | -20.85 | -115.42 | -52.99 |
Change in Accounts Payable | 155.63 | -44.9 | -58.78 | 172.87 | 144.18 |
Change in Other Net Operating Assets | -9.01 | -40.74 | -3.95 | -17.16 | -18.3 |
Operating Cash Flow | 88.69 | -54.66 | -158.4 | -47.72 | 51.53 |
Operating Cash Flow Growth | - | - | - | - | 580.91% |
Capital Expenditures | -97.09 | -321.13 | -53.3 | -55.71 | -52.42 |
Sale of Property, Plant & Equipment | 0.44 | - | - | 56.77 | - |
Sale (Purchase) of Intangibles | -40.4 | -1.71 | - | - | - |
Investment in Securities | - | 0.71 | - | -3.75 | - |
Other Investing Activities | - | 8.05 | - | -0 | -0 |
Investing Cash Flow | -137.05 | -314.07 | -53.3 | -2.69 | -52.42 |
Short-Term Debt Issued | - | 196.92 | - | 85.1 | 10.32 |
Long-Term Debt Issued | 73.19 | 87 | 1.83 | - | 22.96 |
Total Debt Issued | 73.19 | 283.93 | 1.83 | 85.1 | 33.28 |
Short-Term Debt Repaid | -7.82 | - | -16.69 | - | - |
Long-Term Debt Repaid | -17.03 | - | -37.48 | -12.08 | - |
Total Debt Repaid | -24.85 | - | -54.17 | -12.08 | - |
Net Debt Issued (Repaid) | 48.35 | 283.93 | -52.34 | 73.02 | 33.28 |
Issuance of Common Stock | - | - | 349.5 | - | - |
Other Financing Activities | 0 | 0 | 0 | -23.09 | -20.86 |
Financing Cash Flow | 48.35 | 283.93 | 297.16 | 49.94 | 12.42 |
Miscellaneous Cash Flow Adjustments | -0 | - | 0 | - | 0 |
Net Cash Flow | -0.02 | -84.8 | 85.46 | -0.48 | 11.53 |
Free Cash Flow | -8.41 | -375.79 | -211.7 | -103.43 | -0.89 |
Free Cash Flow Margin | -0.48% | -28.19% | -16.08% | -9.03% | -0.10% |
Free Cash Flow Per Share | -0.49 | -21.91 | -12.35 | -8.62 | -0.07 |
Cash Interest Paid | - | 58.94 | 49.97 | 23.09 | 18.18 |
Cash Income Tax Paid | 16.09 | 20.46 | 39.93 | 18.28 | 13.22 |
Levered Free Cash Flow | -40.3 | -389.85 | -211.53 | -161.57 | -25.68 |
Unlevered Free Cash Flow | -5.23 | -376.2 | -199.03 | -154.4 | -14.32 |
Change in Working Capital | -9.25 | -156.01 | -264.41 | -132.15 | -13.98 |